<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Orexin Agonists &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/orexin-agonists/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Sat, 24 Jan 2026 05:38:09 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.0</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>Orexin Agonists &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>Orexin vs. Melatonin: Comparing Fracture Risk</title>
		<link>https://bioengineer.org/orexin-vs-melatonin-comparing-fracture-risk/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Sat, 24 Jan 2026 05:37:50 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[Bone Health]]></category>
		<category><![CDATA[Fracture risk]]></category>
		<category><![CDATA[Fracture Risk Comparison]]></category>
		<category><![CDATA[Melatonin Agonists]]></category>
		<category><![CDATA[Melatonin receptor agonists]]></category>
		<category><![CDATA[Orexin Agonists]]></category>
		<category><![CDATA[Orexin receptor agonists]]></category>
		<category><![CDATA[osteoporosis]]></category>
		<category><![CDATA[osteoporosis treatment]]></category>
		<category><![CDATA[Sleep Disorder Pharmacology]]></category>
		<guid isPermaLink="false">https://bioengineer.org/orexin-vs-melatonin-comparing-fracture-risk/</guid>

					<description><![CDATA[Recent research has shed light on the comparative fracture risk associated with orexin and melatonin receptor agonists, revealing intriguing insights that may impact treatment strategies for patients with conditions affecting bone density and overall skeletal health. In an increasingly aging population where osteoporosis and fractures are significant health concerns, the implications of these findings carry [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">320172</post-id>	</item>
	</channel>
</rss>
